We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Verona Pharma Plc | LSE:VRP | London | Ordinary Share | GB00BYW2KH80 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 55.00 | 45.00 | 65.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
30/4/2021 08:25 | Looks like the americans have started to see through the dire lack of long term progress here and are already fed-up with the jam tomorrow story...... | haff1 | |
23/4/2021 09:02 | Thanks Trevor The news release is a bit lacking in detail and no comment from the investigators, but it sounds like there was no sign of efficacy worth commenting about, so I assume they will not be progressing this any further. It was always a bit of a long shot anyway. | timbo003 | |
23/4/2021 08:13 | Look what came out early doors this morning: Also Q1 results next Thursday 29th April | tradertrev | |
22/4/2021 09:16 | On reflection, the current weakness is more likely to be due to holdings in UK ISAs having to be removed, with some people deciding to sell rather than hold in an ordinary account. Hopefully the effect shouldn't last too much longer. | tradertrev | |
19/4/2021 17:19 | Guessing the read-out from the pilot trial in Covid patients isn't looking too clever. Headline data is due this quarter. Personally I think Covid is just a distraction for VRNA. | tradertrev | |
19/4/2021 16:34 | ...though perhaps less than I might have hoped....... | haff1 | |
16/4/2021 08:30 | Yep...but there is still some hope for the future here .... imho | haff1 | |
15/4/2021 14:55 | Bloody hell this board still going - Clive page and Michael walker totally messed this company up | bangbang1 | |
18/3/2021 15:17 | ...another dissappointing start to the day?....No surprize there.... | haff1 | |
12/3/2021 16:56 | NASDAQ has recold highs...but VRP falls!....no surprize there then...... | haff1 | |
10/3/2021 09:17 | Very good point! | haff1 | |
10/3/2021 08:50 | Amazing to see that a few directors and chairman and others have recently sold shares according to bulletin boards on Nasdaq. Does not say much. Not as if they have no income. Maybe they know it is due a drop or are trying to get some sellers, who knows. I have never known the chairman to sell ever. | shakin not stirred | |
05/3/2021 15:15 | No, but I've just sent them a message asking what's going on. | tradertrev | |
05/3/2021 14:10 | Any idea why H & L are not giving a current price here. | approach3 | |
04/3/2021 12:28 | Boystown Imco yes longstanding investors have seemingly been royally shafted big style. Of course we were due a new appointment just to fool investors into thinking something tantalizing might occur in the next decade just before the patents run out. The £30K salary should get us a couple of days input. Never have I seen such a woefully run R and D pharma company. | shakin not stirred | |
03/3/2021 23:37 | Yes I know. Once they get Ensifentrine through the phase 3 trials, approved by the FDA and launched commercially, we'll still do very well. The stock will be valued at a much higher figure than it ever would have been on the London market. I've only stuck with the investment because the phase 2 clinical trial results look good enough for a commercial product. I don't think the price will do much this year, but next year should see serious growth if everything goes according to plan. Like anyone else who converted from VRP, I'm still up 50%. | drradcliffe | |
03/3/2021 21:07 | Maybe - but I can't help but get the feeling that us long-termers have been gradually "had" over the years | boystown | |
03/3/2021 20:54 | I see her other job is VP at Novartis Gene Therapies where she is in charge of worldwide commercialization. You never know there might be some method in their madness! | drradcliffe | |
03/3/2021 20:49 | The market seem to like it!!! We have dropped by 6.6% today... | haff1 | |
03/3/2021 20:47 | So we have a new non-executive director who is to receive £30,000 a year retainer plus £3000. I'd like to see that much next year out of this share holding? | haff1 | |
25/2/2021 13:29 | There didn't appear to be any new news in the results release, but the Ph3 trial timetable is unchanged which is good. | tradertrev | |
25/2/2021 13:27 | Think the graph here only has the formal trading session prices. $9.88 is a pre-market trade - no idea of volume. | tradertrev | |
25/2/2021 13:16 | NASDAQ graph above is not working? Currently at 9.88? | haff1 | |
16/2/2021 09:44 | Ah ha ... thanks joebloggs2 | haff1 | |
16/2/2021 09:42 | holiday in US | joeblogg2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions